Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma.

San Miguel JF, Weisel KC, Song KW, Delforge M, Karlin L, Goldschmidt H, Moreau P, Banos A, Oriol A, Garderet L, Cavo M, Ivanova V, Alegre A, Martinez-Lopez J, Chen C, Renner C, Bahlis NJ, Yu X, Teasdale T, Sternas L, Jacques C, Zaki MH, Dimopoulos MA

Open source

DOI: 10.3324/haematol.2015.125864
Published: 2015 Oct
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2015.125864,
  title = {Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma.},
  author = {San Miguel JF and Weisel KC and Song KW and Delforge M and Karlin L and Goldschmidt H and Moreau P and Banos A and Oriol A and Garderet L and Cavo M and Ivanova V and Alegre A and Martinez-Lopez J and Chen C and Renner C and Bahlis NJ and Yu X and Teasdale T and Sternas L and Jacques C and Zaki MH and Dimopoulos MA},
  year = {2015},
  journal = {Haematologica},
  doi = {10.3324/haematol.2015.125864},
  url = {https://doi.org/10.3324/haematol.2015.125864}
}

RIS

TY  - JOUR
TI  - Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma.
AU  - San Miguel JF
AU  - Weisel KC
AU  - Song KW
AU  - Delforge M
AU  - Karlin L
AU  - Goldschmidt H
AU  - Moreau P
AU  - Banos A
AU  - Oriol A
AU  - Garderet L
AU  - Cavo M
AU  - Ivanova V
AU  - Alegre A
AU  - Martinez-Lopez J
AU  - Chen C
AU  - Renner C
AU  - Bahlis NJ
AU  - Yu X
AU  - Teasdale T
AU  - Sternas L
AU  - Jacques C
AU  - Zaki MH
AU  - Dimopoulos MA
PY  - 2015
JO  - Haematologica
DO  - 10.3324/haematol.2015.125864
UR  - https://doi.org/10.3324/haematol.2015.125864
ER  -

APA

JF, S. M., KC, W., KW, S., M, D., L, K., H, G., P, M., A, B., A, O., L, G., M, C., V, I., A, A., J, M., C, C., C, R., NJ, B., X, Y., T, T., L, S., C, J., MH, Z., & MA, D. (2015). Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma.. Haematologica. https://doi.org/10.3324/haematol.2015.125864

Source records

pubmed · retrieved 2026-09-25T14:25:48.837Z
doaj · retrieved 2026-09-25T14:25:48.837Z